Publications
Knowledge generated at IrsiCaixa is shared with the scientific community through the publication of articles in high impact scientific journals.
Optimal antiviral switching to minimize resistance risk in HIV therapy.
Ex vivo production of autologous whole inactivated HIV-1 for clinical use in therapeutic vaccines.
Definition of the viral targets of protective HIV-1-specific T cell responses.
Transcriptional profiling of CD4 T cells identifies distinct subgroups of HIV-1 elite controllers.
A therapeutic dendritic cell-based vaccine for HIV-1 infection.
Impact of phenotype definition on genome-wide association signals: empirical evaluation in human immunodeficiency virus type 1 infection.
The HIV-1 integrase genotype strongly predicts raltegravir susceptibility but not viral fitness of primary virus isolates.
Dihydrosphingomyelin impairs HIV-1 infection by rigidifying liquid-ordered membrane domains.
HIV and mature dendritic cells: Trojan exosomes riding the Trojan horse?
Dynamic escape of pre-existing raltegravir-resistant HIV-1 from raltegravir selection pressure.